Irreversible neurologic complications of metrizamide myelography

Kimford Meador, William J. Hamilton, Taher A M El Gammal, K. C. Demetropoulos, Fenwick T Nichols

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.

Original languageEnglish (US)
Pages (from-to)817-821
Number of pages5
JournalNeurology
Volume34
Issue number6
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Metrizamide
Myelography
Nervous System
Contrast Media
Patient Positioning
Neurologic Manifestations
Dehydration
Headache
Seizures

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Neurology

Cite this

Meador, K., Hamilton, W. J., El Gammal, T. A. M., Demetropoulos, K. C., & Nichols, F. T. (1984). Irreversible neurologic complications of metrizamide myelography. Neurology, 34(6), 817-821.

Irreversible neurologic complications of metrizamide myelography. / Meador, Kimford; Hamilton, William J.; El Gammal, Taher A M; Demetropoulos, K. C.; Nichols, Fenwick T.

In: Neurology, Vol. 34, No. 6, 01.01.1984, p. 817-821.

Research output: Contribution to journalArticle

Meador, K, Hamilton, WJ, El Gammal, TAM, Demetropoulos, KC & Nichols, FT 1984, 'Irreversible neurologic complications of metrizamide myelography', Neurology, vol. 34, no. 6, pp. 817-821.
Meador K, Hamilton WJ, El Gammal TAM, Demetropoulos KC, Nichols FT. Irreversible neurologic complications of metrizamide myelography. Neurology. 1984 Jan 1;34(6):817-821.
Meador, Kimford ; Hamilton, William J. ; El Gammal, Taher A M ; Demetropoulos, K. C. ; Nichols, Fenwick T. / Irreversible neurologic complications of metrizamide myelography. In: Neurology. 1984 ; Vol. 34, No. 6. pp. 817-821.
@article{567f1b0c5ab24dd88bf457353ce5ac19,
title = "Irreversible neurologic complications of metrizamide myelography",
abstract = "Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.",
author = "Kimford Meador and Hamilton, {William J.} and {El Gammal}, {Taher A M} and Demetropoulos, {K. C.} and Nichols, {Fenwick T}",
year = "1984",
month = "1",
day = "1",
language = "English (US)",
volume = "34",
pages = "817--821",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Irreversible neurologic complications of metrizamide myelography

AU - Meador, Kimford

AU - Hamilton, William J.

AU - El Gammal, Taher A M

AU - Demetropoulos, K. C.

AU - Nichols, Fenwick T

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.

AB - Metrizamide, a major contrast agent for myelographic procedures, has rarely been reported to cause irreversible neurologic complications. The major transient neurologic alterations include neuropsychological reactions, generalized tonic-clonic seizures, and headaches. Two cases of irreversible spinal neurologic deficits resulting from metrizamide myelography are reported, and the factors that may increase the risks of complications in metrizamide myelographic studies are discussed, including preexisting dehydration, patient positioning, and the concentration of contrast agent.

UR - http://www.scopus.com/inward/record.url?scp=0021247463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021247463&partnerID=8YFLogxK

M3 - Article

C2 - 6539448

AN - SCOPUS:0021247463

VL - 34

SP - 817

EP - 821

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -